REGN - Stock Quote for Regeneron Pharmaceuticals Inc

|CustomizeREGN quote (NASDAQ Exchange)

18.34 -0.32 -1.71%fyi
After Hours: 18.56 +0.22/+1.18% Vol. 2,452
Previous Close	18.66	Bid	17.43
fyi Open	18.69	Bid Size	1,000
Day's High	18.88	Ask	18.35
Day's Low	18.30	Ask Size	200
Volume	353,077	52 Week High	23.49
Avg. Daily Vol. (13 wk.)	579,218	52 Week Low	11.81

REGN Intraday Chart

5d 1m 3m 1y 3y 5y 10y

Beta	1.24
Dividend & Yield	NA
Earnings/Share	-0.79
Forward P/E	-15.54
Market Cap.	1.48 Bil
P/E	-22.64
Return on Equity	-14.63
Total Shares Out.	80.49 Mil

Quotes delayed 15 min unless otherwise indicated

Last trade (extended hours) 4:10 PM ET Financial data in U.S. dollars

Sponsored sites
The Hartford Insurance - AARP.TheHartford.com
If You're Over 50 Then You Can Save Up To $402 On Insurance Now!
100% Accurate Stock Picks - BestDamnPennyStocks.com
Perfect 2009 Track Record/ Some picks rising over 800%! Free Sign Up

Your latest quotes: DBRN, DINRF, BKE, GMTN, FJSCX, REGN

News about REGN

Market Report -- In Play (REGN) 11/10/2009 Briefing.com
Sanofi-Aventis, Regeneron extend development deal 11/10/2009 Associated Press
View all REGN news

Press releases

Regeneron Announces Presentation at the 21st Annual Piper Jaffray Healthcare Conference Yesterday PR Newswire
Regeneron Announces Conference Call to Discuss Expanded Antibody Collaboration with Sanofi-aventis 11/10/2009 PR Newswire
View all REGN news

News from the Web

4 Platform Drugmakers to Invest In Yesterday At Motley Fool
Sanofi's Research Shift: Billion-Dollar Deal, Venture Capital Fund 11/11/2009 At Wall Street Journal
Sanofi-Aventis, Regeneron expand antibody efforts 11/11/2009 At MarketWatch
View all REGN news

Videos about REGN

Latest biotech stock news

PARD's Picoplatin targets for US approval next year, More biotech updates from ARQL, DNDN, MDVN, REGN, CRIS, ARIA, See our real money trades free real-time on...